Sputnik V became the most exported drug in Russia in two years
The most exported medical product in RUSSIA is the Sputnik V vaccine against the new CORONAVIRUS infection.The first Russian vaccine was registered in Russia two years ago
The Sputnik V coronavirus vaccine has become the most exported drug in Russian history in the two years since its registration. This was announced to RBC by the DIRECTOR General of the Russian Direct Investment Fund Kirill Dmitriev. With the support of this investment fund, the production of the drug was organized in Russia and abroad.
“Over the past two years since registration, the Sputnik V vaccine has become the most exported drug in the history of Russia and has rightfully established itself as one of the most effective and safe tools to combat coronavirus infection in the world. This is confirmed by the results of more than 50 clinical studies and data from the use of Sputnik V as part of national vaccination programs in various regions of the world, including Europe, Asia, the Middle East and Latin America,” Dmitriev said.
Scientists have discovered in Russia a new strain of coronavirus "Russian deltacron" Society
Russian President Vladimir Putin announced the registration of the first Russian vaccine against coronavirus infection Sputnik V on August 11, 2020 at a meeting with the government.
The two-component drug was developed by the National Research Center for Epidemiology and Microbiology. N.F. Gamalei (NICEM). According to the results of the third phase of trials of "Sputnik V", published in the journal Lancet, the effectiveness of the vaccine is 91.6%
RDIF was established in 2011 at the initiative of the President. The Fund makes direct investments in leading and promising Russian companies together with other major investors, including those from foreign countries. The volume of investments is more than 2.1 trillion rubles, of which more than 200 billion rubles. — RDIF funds and 1.9 trillion rubles. - partner funds.
The first foreign country to register the drug was Belarus. By August, 2022 Sputnik V is registered in 71 countries of the world where more than 4 billion people in total live, RBC Dmitriev reported. RDIF has also created an international network of manufacturing partners — vaccine production is localized in 18 countries around the world.
Read on RBC Pro Pro From 2009 to 2022:how offices in Moscow were tempered in crises Forecasts Pro What does the Swiss tax system offer to Russian businessmen:article review Pro "I wake up while the world sleeps": why the ex-head of Disney gets up at 4.15am Articles Pro How Pakistan came to the brink of default and which countries will be next Articles ProWhy selling Netflix is only a matter of timeHow the industry is changing Predictions Pro "Adult Playground":What It's Like to Work at GOOGLE in 6 Points Articles Pro What is toxic productivity and how to overcome it InstructionsAlso, with the support of RDIF, a single-component vaccine Sputnik V was developed, this version of the vaccine was registered in Russia on May 6, 2021. Now this version of the vaccine is used in more than 30 countries. RDIF also initiated and funded joint research with other leading vaccine manufacturers to create “vaccine cocktails” with Sputnik Light.
Sputnik Light is a universal booster for other vaccines and provides higher protection against the Omicron strain and other mutations,” Dmitriev said.
In Russia, the maximum number of cases of covid was revealed since the end of March Society
In addition to Sputnik V and Sputnik Light, the vaccines EpiVacCorona (developed by the Novosibirsk Center Vector) and Kovivak (developed by the Chumakov Center) are registered and used in Russia.
As of August 11, 89.2 million people were fully vaccinated in Russia. Herd immunity is 8.6%